• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
  • Menu

120 years since the birth of Zinaida Ermolyeva

24.10.2018/in News /by Evgeniy Makarevich

Zinaida Yermolyeva saved thousands of people during World War II by developing a new type of antibiotics. Abroad, she is also called the “Penicillin Mistress”.

Zinaida Yermolyeva was born in 1898 in the Region of the Don Cossacks – this is how Volgograd Region was called before. In 1921, she graduated from the Women’s Medical Institute in Rostov.

In the second year of study, Zinaida Yermolyeva became fascinated with microbiology and dedicated her entire life to it. At the same time, a cholera epidemic in 1922 had a great influence on it, which swept across the region like a tornado. At that time, she almost died when she drank a liquid with cholera-like vibrios, which she herself had isolated from tap water. A few hours later, Yermolyeva became seriously ill but was able to overcome the disease. Thus, she proved that vibrios are the causative agents of cholera – it is thanks to her discovery that since then water has been chlorinated in public places.

In 1925, Zinaida Ermolieva moved to Moscow. Up until the epidemic in Afghanistan in 1939 and beyond, she continued to develop methods for diagnosing and fighting cholera, for which she was soon given the title of professor.

During the war, she arrived at the besieged Stalingrad, where a cholera epidemic could begin. Zinaida Yermolyeva, in the most difficult conditions, launched the production of bacteriophage, chlorinated public wells and launched mass vaccination. For this, she was awarded the Stalin Prize.

During World War II, penicillin was developed in the West. Later, Howard Florey won the Nobel Prize. However, no one wanted to immediately share the revolutionary discovery with the USSR, so Zinaida Yermolyeva was instructed to develop a Soviet analog of the antibiotic.

The crustosin was even more effective than its western original. Howard Florey, who arrived in the USSR, was delighted with the work of his Soviet colleague, whom he called “Ms. Penicillin.” This nickname was firmly established for Zinaida Yermolyeva – not only here, but also abroad.

Up until his death in 1974, Zinaida Yermolyeva was engaged in microbiology and antibiotics in particular. Thanks to her discoveries, drugs were created that still do not leave the pharmacy shelves: levomycetin, streptomycin and interferon.

Link: www.5-tv.ru

Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

YOU MAY ALSO BE INTERESTED IN

Publications
Readability User Testing of Package Information Leaflets (PIL) in EAEU
Read More
Publications
Remote clinical trial monitoring
Read More
Publications
Post-authorization studies of drug safety in Russia
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

2 + 2 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
Ministry of Health is in favor of lifting the ban on the cultivation of opium... What do people know about clinical trials?
Scroll to top